Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations von Ye, Patrick Peiyong, Woodward, Brian D., Langpap, Sydne, Viens, Robb, Shelburne, Katherine, Zhou, Wen, Zhu, Joyce, Wignall, Jan, Searle, Naomi, Varga, Matthew Gordon, Palmer, Gary A., Tsao, David, Atay, Oguzhan, Husain, Hatim

Volltext

Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With Immunotherapy Response in NSCLC von Hsiao, Angela, Woodward, Brian, Ye, Patrick, Varga, Matthew G, Altaie, Ghaith, Lu, Kevin, Searle, Naomi, Viens, Robb, Langpap, Sydne, Li, Zeqian, Palmer, Gary, Husain, Hatim

Volltext

Abstract 526: Novel methylation-based, tissue-free ctDNA assay accurately quantifies longitudinal tumor burden changes for precision treatment monitoring von Ye, Patrick Peiyong, Viens, Robb, Bower, Xavier, Riku, Shan, Tsao, David, Atay, Oguzhan

Volltext

Abstract 5588: Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy von Ye, Patrick, Woodward, Brian, Viens, Robb, Langpap, Sydne, Shelburne, Katherine, Zhou, Wen, Zhu, Joyce, Wignall, Jan, Palmer, Gary, Tsao, David, Atay, Oguzhan, Husain, Hatim

Volltext